Brinter raises €1.2M in seed funding to accelerate 3D printing bioscience research and manufacturing for uses that range from personalized drugs to human spare parts
Turku-based bioprinting startup Brinter has today announced the successful closure of a €1.2M seed funding round led by early-stage VC Innovestor . The company will use the capital to further expand its operations internationally in Europe and the US. Brinter aims to put bioprinting within reach of every pharmaceutical company, hospital, university, and research center.
Medical research facilities and universities often still rely on traditional methods of discovery in the research of new drugs, understanding diseases, and finding